Agency Information Collection Activities: Proposed Collection; Comment Request, 104545-104546 [2024-30620]
Download as PDF
Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices
program, you may contact Anne Pesto,
Senior Advisor, Marketplace Eligibility
and Enrollment Group, Center for
Consumer Information and Insurance
Oversight, Centers for Medicare &
Medicaid Services, at 667–290–9486, by
email at anne.pesto@cms.hhs.gov, or by
mail at 7500 Security Blvd., Baltimore,
MD 21244.
SUPPLEMENTARY INFORMATION: The
Privacy Act of 1974, as amended (5
U.S.C. 552a) provides certain
protections for individuals applying for
and receiving Federal benefits. The law
governs the use of computer matching
by Federal agencies when records in a
system of records (meaning, Federal
agency records about individuals
retrieved by name or other personal
identifier) are matched with records of
other Federal or non-Federal agencies.
The Privacy Act requires agencies
involved in a matching program to:
1. Enter into a written agreement,
which must be prepared in accordance
with the Privacy Act, approved by the
Data Integrity Board of each source and
recipient Federal agency, provided to
Congress and the Office of Management
and Budget (OMB), and made available
to the public, as required by 5 U.S.C.
552a(o), (u)(3)(A), and (u)(4).
2. Notify the individuals whose
information will be used in the
matching program that the information
they provide is subject to verification
through matching, as required by 5
U.S.C. 552a(o)(1)(D).
3. Verify match findings before
suspending, terminating, reducing, or
making a final denial of an individual’s
benefits or payments or taking other
adverse action against the individual, as
required by 5 U.S.C. 552a(p).
4. Report the matching program to
Congress and the OMB, in advance and
annually, as required by 5 U.S.C.
552a(o) (2)(A)(i), (r), and (u)(3)(D).
5. Publish advance notice of the
matching program in the Federal
Register as required by 5 U.S.C.
552a(e)(12).
This matching program meets these
requirements.
khammond on DSK9W7S144PROD with NOTICES
Barbara Demopulos,
Privacy Act Officer, Division of Security,
Privacy Policy and Governance, Office of
Information Technology, Centers for Medicare
& Medicaid Services.
Participating Agencies
The Department of Health and Human
Services (HHS), Centers for Medicare &
Medicaid Services (CMS) is the
recipient agency, and the Department of
the Treasury (Treasury), Internal
Revenue Service (IRS) is the source
agency.
VerDate Sep<11>2014
17:03 Dec 20, 2024
Jkt 265001
Authority for Conducting the Matching
Program
The authority for the matching
program is 42 U.S.C. 18001, et seq.
Purpose(s)
The purpose of the matching program
is to provide CMS with IRS Federal tax
information which CMS and State-based
administering entities (AEs) will use to
verify household income and family
size for applicants and enrollees
receiving eligibility determinations and
redeterminations for benefits under the
Patient Protection and Affordable Care
Act (PPACA), including: enrollment in
a Qualified Health Plan (QHP) or a
State’s Basic Health Plan (BHP) through
the federally-facilitated Exchange (FFE)
or a State-based Exchange (SBE);
advance payments of the premium tax
credit (APTC); a cost sharing reduction
(CSR); enrollment in Medicaid and the
Children’s Health Insurance Program
(CHIP); and certain certificates of
exemption.
Categories of Individuals
Categories of Records
The categories of records used in the
matching program are identity
information and Federal tax information
(specifically, household income and
family size information). To request
Federal tax information from IRS, CMS
will provide IRS with the relevant
taxpayer’s name, social security number
(SSN), and relationship to the
applicant(s) or enrollee(s) (i.e., primary,
spouse, or dependent). When IRS is able
to match the SSN and name provided by
CMS and Federal tax information is
available, IRS will disclose to CMS the
following items of Federal tax
information with respect to that
taxpayer:
1. SSN;
2. family size;
3. filing status;
4. modified adjusted gross income
(MAGI);
5. taxable Social Security benefits;
6. adjusted gross income (AGI) for
adjusted tax returns;
7. taxable year with respect to which
the preceding information relates or, if
Frm 00035
Fmt 4703
Sfmt 4703
applicable, the fact that such
information is not available; and
8. any other specified item of Federal
tax information (FTI) authorized
pursuant to 26 U.S.C. 6103(1)(21) and
its implementing regulations.
System(s) of Records
The records used in this matching
program will be disclosed from the
following systems of records, as
authorized by routine uses published in
the System of Records Notices (SORNs)
cited below:
A. System of Records Maintained by
CMS
• CMS Health Insurance Exchanges
System (HIX), CMS System No. 09–70–
0560, last published in full at 78 FR
63211 (Oct. 23, 2013), as amended at 83
FR 6591 (Feb. 14, 2018).
B. System of Records Maintained by IRS
• FTI Treasury/IRS 24.030, published
at 80 FR 54064 (Sept. 8, 2015).
[FR Doc. 2024–30522 Filed 12–20–24; 8:45 am]
BILLING CODE 4120–03–P
The individuals whose information
will be used in the matching program
are consumers (applicants and
enrollees) who receive the eligibility
determinations and redeterminations
described in the preceding Purpose(s)
section (in particular, taxpayers whose
Federal tax information is requested
from IRS to verify an applicant’s or
enrollee’s household income and family
size).
PO 00000
104545
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10630 and
CMS–10798]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
SUMMARY:
E:\FR\FM\23DEN1.SGM
23DEN1
104546
Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
February 21, 2025.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
khammond on DSK9W7S144PROD with NOTICES
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10630 The PACE Organization
(PO) Monitoring and Audit Process
CMS–10798 Application for Part B
Immunosuppressive Drug Coverage
(Part B–ID)
Under the PRA (44 U.S.C. 3501–
3520), Federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
VerDate Sep<11>2014
17:03 Dec 20, 2024
Jkt 265001
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires Federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collections
1. Type of Information Collection
Request: Revision of a currently
approved information collection; Title
of Information Collection: The PACE
Organization (PO) Monitoring and Audit
Process; Use: Sections 1894(e)(4) and
1934(e)(4) of the Act and the
implementing regulations at 42 CFR
460.190 and 460.192 mandate that CMS,
in conjunction with the SAA, audit POs
annually for the first 3 years (during the
trial period), and then on an ongoing
basis following the trial period. The
information gathered during this audit
will be used by the Medicare Parts C
and D Oversight and Enforcement
Group (MOEG) within the Center for
Medicare (CM), as well as the SAA, to
assess POs’ compliance with PACE
program requirements. If outliers or
other data anomalies are detected, other
offices within CMS will work in
collaboration with MOEG for follow-up
and resolution. Additionally, POs will
receive the audit results and will be
required to implement corrective action
to correct any identified deficiencies.
Information collected from the POs
for use in the audit is obtained
electronically through the Health Plan
Management System (HPMS). HPMS is
a system that was developed and is
maintained by CMS and is used to
securely transmit information between
CMS and POs. All POs have access to
HPMS, and users create and maintain a
secure user id and password that is used
each time HPMS is accessed. Form
Number: CMS–10630 (OMB control
number: 0938–1327); Frequency:
Annually; Affected Public: Private
Sector, State, Local, or Tribal
Governments, Business or other forprofits, Not-for-profits institutions;
Number of Respondents: 40; Total
Annual Responses: 43; Total Annual
Hours: 31,200. (For policy questions
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
regarding this collection contact Katrina
Hoadley at 410–786–8480 or
katrina.hoadley@cms.hhs.gov).
2. Type of Information Collection
Request: Revision of a currently
approved information collection; Title:
Application for Part B
Immunosuppressive Drug Coverage
(Part B–ID); Use: Sections 226A, 1836(b)
and 1837(n) of the Act provide the
statutory authority for this new, limited
Medicare entitlement program. It is
stated in § 407.1(a)(6) that, sections
1836(b) and 1837(n) of the Act provide
for coverage of immunosuppressive
drugs as described in section
1861(s)(2)(J) of the Act under Part B
beginning on or after January 1, 2023,
for eligible individuals whose benefits
under Medicare Part A and eligibility to
enroll in Part B on the basis of ESRD
would otherwise end with the 36th
month after the month in which the
individual receives a kidney transplant
by reason of section 226A(b)(2) of the
Act.
The CMS–10798 provides the
necessary information to determine
eligibility and to process the
beneficiary’s request for enrollment for
in Part B–ID coverage. This form is only
used for enrollment by beneficiaries
whose Medicare entitlement based on
ESRD would otherwise end after a
successful kidney transplant to continue
enrollment under Medicare Part B only
for the coverage of immunosuppressive
drugs who already have Part A, but not
Part B.
Form CMS–10798 is completed by the
individual or is completed by an SSA
representative using information
provided by the Medicare enrollee
during a telephone interview. The form
is owned by CMS, but not completed by
CMS staff. SSA processes Medicare
enrollments on behalf of CMS. Form
Number: CMS–10798 (OMB control
number: 0938–1428); Frequency: Once;
Affected Public: Individuals and
Households, State, Local, or Tribal
Governments; Number of Respondents:
1,019; Total Annual Responses: 1,019;
Total Annual Hours: 173. (For policy
questions regarding this collection
contact Tyrissa Woods at 410–786–0286
or Tyrissa.woods@cms.hhs.gov.)
William N. Parham, III,
Director, Division of Information Collections
and Regulatory Impacts, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2024–30620 Filed 12–20–24; 8:45 am]
BILLING CODE 4120–01–P
E:\FR\FM\23DEN1.SGM
23DEN1
Agencies
[Federal Register Volume 89, Number 246 (Monday, December 23, 2024)]
[Notices]
[Pages 104545-104546]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30620]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10630 and CMS-10798]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), Federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of information
(including each proposed extension or reinstatement of an existing
collection of information) and to allow 60 days for public comment on
the proposed action. Interested persons are invited to send comments
regarding our burden estimates or any other aspect of this collection
of information, including the necessity and utility of the proposed
information collection for the proper performance of the agency's
functions, the accuracy of the estimated burden, ways to enhance the
quality, utility, and
[[Page 104546]]
clarity of the information to be collected, and the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
DATES: Comments must be received by February 21, 2025.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: ___, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10630 The PACE Organization (PO) Monitoring and Audit Process
CMS-10798 Application for Part B Immunosuppressive Drug Coverage (Part
B-ID)
Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires Federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collections
1. Type of Information Collection Request: Revision of a currently
approved information collection; Title of Information Collection: The
PACE Organization (PO) Monitoring and Audit Process; Use: Sections
1894(e)(4) and 1934(e)(4) of the Act and the implementing regulations
at 42 CFR 460.190 and 460.192 mandate that CMS, in conjunction with the
SAA, audit POs annually for the first 3 years (during the trial
period), and then on an ongoing basis following the trial period. The
information gathered during this audit will be used by the Medicare
Parts C and D Oversight and Enforcement Group (MOEG) within the Center
for Medicare (CM), as well as the SAA, to assess POs' compliance with
PACE program requirements. If outliers or other data anomalies are
detected, other offices within CMS will work in collaboration with MOEG
for follow-up and resolution. Additionally, POs will receive the audit
results and will be required to implement corrective action to correct
any identified deficiencies.
Information collected from the POs for use in the audit is obtained
electronically through the Health Plan Management System (HPMS). HPMS
is a system that was developed and is maintained by CMS and is used to
securely transmit information between CMS and POs. All POs have access
to HPMS, and users create and maintain a secure user id and password
that is used each time HPMS is accessed. Form Number: CMS-10630 (OMB
control number: 0938-1327); Frequency: Annually; Affected Public:
Private Sector, State, Local, or Tribal Governments, Business or other
for-profits, Not-for-profits institutions; Number of Respondents: 40;
Total Annual Responses: 43; Total Annual Hours: 31,200. (For policy
questions regarding this collection contact Katrina Hoadley at 410-786-
8480 or [email protected]).
2. Type of Information Collection Request: Revision of a currently
approved information collection; Title: Application for Part B
Immunosuppressive Drug Coverage (Part B-ID); Use: Sections 226A,
1836(b) and 1837(n) of the Act provide the statutory authority for this
new, limited Medicare entitlement program. It is stated in Sec.
407.1(a)(6) that, sections 1836(b) and 1837(n) of the Act provide for
coverage of immunosuppressive drugs as described in section
1861(s)(2)(J) of the Act under Part B beginning on or after January 1,
2023, for eligible individuals whose benefits under Medicare Part A and
eligibility to enroll in Part B on the basis of ESRD would otherwise
end with the 36th month after the month in which the individual
receives a kidney transplant by reason of section 226A(b)(2) of the
Act.
The CMS-10798 provides the necessary information to determine
eligibility and to process the beneficiary's request for enrollment for
in Part B-ID coverage. This form is only used for enrollment by
beneficiaries whose Medicare entitlement based on ESRD would otherwise
end after a successful kidney transplant to continue enrollment under
Medicare Part B only for the coverage of immunosuppressive drugs who
already have Part A, but not Part B.
Form CMS-10798 is completed by the individual or is completed by an
SSA representative using information provided by the Medicare enrollee
during a telephone interview. The form is owned by CMS, but not
completed by CMS staff. SSA processes Medicare enrollments on behalf of
CMS. Form Number: CMS-10798 (OMB control number: 0938-1428); Frequency:
Once; Affected Public: Individuals and Households, State, Local, or
Tribal Governments; Number of Respondents: 1,019; Total Annual
Responses: 1,019; Total Annual Hours: 173. (For policy questions
regarding this collection contact Tyrissa Woods at 410-786-0286 or
[email protected].)
William N. Parham, III,
Director, Division of Information Collections and Regulatory Impacts,
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-30620 Filed 12-20-24; 8:45 am]
BILLING CODE 4120-01-P